Effects of two oral contraceptives, containing 30 or 20 μg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women

被引:0
作者
Ferreira, ACP
Montes, MBA
Franceschini, SA
Toloi, MRT
机构
[1] USP, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Toxicol & Bromatol Anal, BR-14040903 Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynaecol, BR-01051 Sao Paulo, Brazil
来源
INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE | 2001年 / 46卷 / 05期
关键词
oral contraceptives; blood coagulation; fibrinolysis; hemostasis; ethinyl estradiol; gestodene;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective-Blood coagulation and fibrinolytic variables were evaluated in 46 Brazilian women treated with either of two monophasic oral contraceptives (OC), containing 30 or 20 mug of ethinyl estradiol, and 75 mug of gestodene. Methods-The effects on procoagulants, anticoagulants, pro-fibrinolytics and antifibrinolytics and fibrin turnover were evaluated after treatment for six consecutive cycles, the impact of reduction of ethinyl estradiol dosage on these effects being assessed. Results-The OC containing 30 mug of ethinyl estradiol significantly increased the activities of factors VIII and X, whereas the one containing 20 mug of ethinyl estradiol caused no changes in clotting factors. Neither treatment altered fibrinogen levels or factor VII, IX or XII activity. There were no changes in antithrombin levels, but treatment with 30 mug ethinyl estradiol increased protein C levels and treatment with 20 mug decreased total protein S levels. Concerning the fibrinolytic parameters, both OCs increased plasminogen activity, whereas no changes in PAI-I, t-PA, alpha-2-antiplasmin or fibrin degradation products were observed. The reduction in ethinyl estradiol dosage from 30 mug to 20 mug eliminated the effects on factors VIII and X. Conclusions-The results show that the OC studied did not cause sufficient changes to indicate that there may be a correlation between these laboratory alterations and clinical results. The lack of reports concerning the hemostatic effects of OCs on Brazilian women hinders comparison of the present data with those obtained for other ethnic groups, at different geographical locations, and emphasizes the importance of such a study for future epidemiological investigation of the prothrombotic effects of OCs in Brazilian women.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 50 条
[21]   A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism:: 20 μg ethinyl estradiol combined with 100 μg levonorgestrel [J].
Skouby, SO ;
Endrikat, J ;
Düsterberg, B ;
Schmidt, W ;
Gerlinger, C ;
Wessel, J ;
Goldstein, H ;
Jespersen, J .
CONTRACEPTION, 2005, 71 (02) :111-117
[22]   Modulation of ovarian function by an oral contraceptive containing 30 mu g ethinyl estradiol in combination with 2.00 mg dienogest [J].
Spona, J ;
Feichtinger, W ;
Kindermann, C ;
Moore, C ;
Mellinger, U ;
Walter, F ;
Graser, T .
CONTRACEPTION, 1997, 56 (03) :185-191
[23]   Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol [J].
Kluft, Cornelis ;
Zimmerman, Yvette ;
Mawet, Marie ;
Klipping, Christine ;
Duijkers, Ingrid J. M. ;
Neuteboom, Jacoline ;
Foidart, Jean-Michel ;
Bennink, Herjan Coelingh .
CONTRACEPTION, 2017, 95 (02) :140-147
[24]   Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial [J].
Gersten, Janet ;
Hsieh, Jennifer ;
Weiss, Herman ;
Ricciotti, Nancy A. .
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2016, 29 (06) :635-642
[25]   Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol [J].
Jick, SS ;
Kaye, JA ;
Russmann, S ;
Jick, H .
CONTRACEPTION, 2006, 73 (03) :223-228
[26]   Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene [J].
Endrikat, J ;
Gerlinger, C ;
Cronin, M ;
Ruebig, A ;
Schmidt, W ;
Düsterberg, B .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (03) :159-166
[27]   A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 mu g ethinylestradiol 75 mu g gestodene and 30 mu g ethinylestradiol 75 mu g gestodene, with respect to efficacy, cycle control, and tolerance [J].
Endrikat, J ;
Muller, U ;
Dusterberg, B .
CONTRACEPTION, 1997, 55 (03) :131-137
[28]   Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest [J].
Wiegratz, Inka ;
Mittmann, Katrin ;
Dietrich, Horst ;
Zimmermann, Thomas ;
Kuhl, Herbert .
FERTILITY AND STERILITY, 2006, 85 (06) :1812-1819
[29]   The Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes [J].
Emmerson, Odette ;
Bester, Janette ;
Lindeque, Barend G. ;
Swanepoel, Albe C. .
MICROSCOPY AND MICROANALYSIS, 2018, 24 (06) :713-728
[30]   Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®) [J].
Archer, DF ;
Maheux, R ;
DelConte, A ;
O'Brien, FB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) :S39-S44